# Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

> **NCT00930982** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 124 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Ciprofloxacin (Cipro, BAYQ3939)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00930982
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2014-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930982, "Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00930982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*